TRACON Pharmaceuticals Inc (TCON) - Financial and Strategic SWOT Analysis Review



TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TJ004309, TRC253, TRC694, and TRC205. Its lead product TRC105, is an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with VEGF inhibitors. TRC102 is a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma. In addition, it also offers products for the treatment of fibrosis, prostate cancer, and hematologic malignancies such as myeloma. The company works in collaboration with universities and medical institutions. TRACON is headquartered in San Diego, California, the US.

TRACON Pharmaceuticals Inc Key Recent Developments

May 13,2020: TRACON Pharmaceuticals reports first quarter 2020 financial results and provides corporate update
Apr 14,2020: TRACON Pharmaceuticals announces appointment of Biotechnology Industry Veteran Shahe Garabedian as Senior Vice President of Quality Assurance and granting of inducement award
Mar 19,2020: TRACON Pharmaceuticals announces appointment of Saundra Pelletier to Board of Directors
Feb 27,2020: TRACON Pharmaceuticals reports fourth quarter and year-end 2019 financial results and provides corporate update
Nov 05,2019: TRACON Pharmaceuticals reports third quarter 2019 financial results and provides corporate update

This comprehensive SWOT profile of TRACON Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of TRACON Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

TRACON Pharmaceuticals Inc - Key Information
TRACON Pharmaceuticals Inc - Overview
TRACON Pharmaceuticals Inc - Key Employees
TRACON Pharmaceuticals Inc - Key Employee Biographies
TRACON Pharmaceuticals Inc - Key Operational Heads
TRACON Pharmaceuticals Inc - Major Products and Services
TRACON Pharmaceuticals Inc - History
TRACON Pharmaceuticals Inc - Company Statement
TRACON Pharmaceuticals Inc - Locations And Subsidiaries
TRACON Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

TRACON Pharmaceuticals Inc - Business Description
TRACON Pharmaceuticals Inc - Corporate Strategy
TRACON Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
TRACON Pharmaceuticals Inc - Strengths
TRACON Pharmaceuticals Inc - Weaknesses
TRACON Pharmaceuticals Inc - Opportunities
TRACON Pharmaceuticals Inc - Threats
TRACON Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Performance Charts

TRACON Pharmaceuticals Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



TRACON Pharmaceuticals Inc, Key Information
TRACON Pharmaceuticals Inc, Key Ratios
TRACON Pharmaceuticals Inc, Share Data
TRACON Pharmaceuticals Inc, Major Products and Services
TRACON Pharmaceuticals Inc, History
TRACON Pharmaceuticals Inc, Key Employees
TRACON Pharmaceuticals Inc, Key Employee Biographies
TRACON Pharmaceuticals Inc, Key Operational Heads
TRACON Pharmaceuticals Inc, Other Locations
TRACON Pharmaceuticals Inc, Subsidiaries
TRACON Pharmaceuticals Inc, Key Competitors
TRACON Pharmaceuticals Inc, SWOT Analysis
TRACON Pharmaceuticals Inc, Ratios based on current share price
TRACON Pharmaceuticals Inc, Annual Ratios
TRACON Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



TRACON Pharmaceuticals Inc, Performance Chart
TRACON Pharmaceuticals Inc, Ratio Charts
 


Rocket Pharmaceuticals Inc (RCKT) - Financial and Strategic SWOT Analysis Review

Rocket Pharmaceuticals Inc (Rocket Pharma), formerly Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of novel therapeutics for the treatment of glaucoma and

USD 300 View Report

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available